tirzepatide in children Big update pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ A Study to Evaluate Tirzepatide
Description
With tirzepatide, people can see lower blood sugar levels, better glycemic control, and reduction of low blood sugar occurrences, as well as weight reduction after receiving doses of mg of tirzepatide

Cagrilintide Safety and Risks As with any investigational peptide , cagrilintide should be used with clinical caution , particularly in populations with pre-existing endocrine or gastrointestinal disorders

Dose Range: From 0.25 mg up to about 4.5 mg weekly in advanced protocols, increased gradually [1]
The danger of mixing them up Your chart says draw 25 units for a 2.5mg dose at 10mg/mL
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)